Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

quisinostat × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1

Interventions

pembrolizumab 1124 Specimen Handling 796 Carboplatin 747 Magnetic Resonance Spectroscopy 722 Cyclophosphamide 720 Cisplatin 641 Nivolumab 628 Paclitaxel 560 Radiotherapy 533 Gemcitabine 496 Biopsy 484 Bevacizumab 421 Dexamethasone 398 Docetaxel 352 fludarabine 350 venetoclax 343 atezolizumab 327 Fluorouracil 326 Oxaliplatin 324 Capecitabine 319 Rituximab 315 durvalumab 302 Drug Therapy 299 Doxorubicin 285 Radiosurgery 285 Pemetrexed 281 Ipilimumab 276 Standard of Care 275 Blood Specimen Collection 274 Radiation 259

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06932757 2025-06-03

Adjuvant Quisinostat in High-Risk Uveal Melanoma

University of Miami

Phase 2 Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡